Rang	Name	Position
1	Mr. Curran M. Simpson M.S.	President, CEO & Director
2	Mr. Patrick J. Christmas II, J.D.	Executive VP & Chief Strategy and Legal Officer
3	Dr. Stephen Pakola M.D.	Executive VP & Chief Medical Officer
4	Mr. Mitchell Chan M.B.A.	Executive VP & CFO
5	Mr. Craig Malzahn	Executive VP of Product Development & CTO
6	Dr. Olivier Danos Ph.D.	Executive VP & Chief Scientific Officer
7	Ms. Shiva G. Fritsch	Chief Communications & People Officer
8	Dr. Ram Palanki Pharm.D.	Executive VP & Chief Commercial Officer
9	Ms. Nina Hunter	SVP of Global Regulatory Strategy and Quality
10	Dr. Jahannaz Dastgir D.O.	Clinical Development Lead

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	8,80%	49,57 Mio. USD
2	Redmile Group, LLC	6,65%	37,45 Mio. USD
3	JPMorgan Chase & Co	5,30%	29,86 Mio. USD
4	State Street Corp	4,16%	23,42 Mio. USD
5	Morgan Stanley - Brokerage Accounts	3,15%	17,71 Mio. USD
6	Vanguard Capital Management, LLC	3,06%	17,21 Mio. USD
7	The Goldman Sachs Group Inc	2,80%	15,77 Mio. USD
8	Qube Research & Technologies	2,00%	11,23 Mio. USD
9	Geode Capital Management, LLC	1,73%	9,75 Mio. USD
10	AQR Capital Management LLC	1,60%	9,02 Mio. USD
11	Vanguard Portfolio Management, LLC	1,55%	8,73 Mio. USD
12	Integral Health Asset Management, LLC	1,22%	6,86 Mio. USD
13	Dimensional Fund Advisors, Inc.	1,11%	6,27 Mio. USD
14	D. E. Shaw & Co LP	1,09%	6,11 Mio. USD
15	Two Sigma Investments LLC	1,02%	5,74 Mio. USD
16	Citadel Advisors Llc	1,02%	5,74 Mio. USD
17	Nuveen, LLC	0,89%	4,99 Mio. USD
18	22NW, LP	0,75%	4,22 Mio. USD
19	Millennium Management LLC	0,73%	4,12 Mio. USD
20	Pale Fire Capital SE	0,71%	4,00 Mio. USD